Source link : https://www.newshealth.biz/health-news/study-backs-skipping-5-fu-bolus-in-chemo-regimens-for-gastrointestinal-cancers/
Omitting bolus 5-fluorouracil (5-FU) from combination chemotherapy for gastrointestinal (GI) cancers did not adversely affect survival and was associated with less toxicity, a review of a large commercial database showed. Across multiple types of GI cancers, patients who did not receive bolus 5-FU had overall survival that was almost identical to that of patients who […]
Author : News Health
Publish date : 2024-09-05 20:10:48
Copyright for syndicated content belongs to the linked Source.